Computer-Aided Drug Discovery Market Size, Share, Growth, and Industry Analysis, By Types (Ligand-Based Drug Design, Sequence-Based Approaches, Structure-Based Drug Design, ), By Applications (Biotechnology Companies, Pharmaceutical Companies, Research Laboratories, ) , and Regional Insights and Forecast to 2035

Table of Content



1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Computer-Aided Drug Discovery Market Size

1.3 Market Segmentation

1.4 Regulatory Environment



2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 Computer-Aided Drug Discovery Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 Computer-Aided Drug Discovery Business Mode and Production Process

2.3.1 Computer-Aided Drug Discovery Business Mode Analysis

2.3.2 Production Process Analysis

2.4 Computer-Aided Drug Discovery Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of Computer-Aided Drug Discovery

2.4.2 Raw Material Cost of Computer-Aided Drug Discovery

2.4.3 Labor Cost of Computer-Aided Drug Discovery

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis



3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War



4 Market Competitive Landscape

4.1 Global Computer-Aided Drug Discovery Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global Computer-Aided Drug Discovery Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global Computer-Aided Drug Discovery Price by Manufacturer (2021-2026)

4.4 Computer-Aided Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of Computer-Aided Drug Discovery, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of Computer-Aided Drug Discovery, Product Offered and Application

4.7 Computer-Aided Drug Discovery Market Competitive Situation and Trends

4.7.1 Computer-Aided Drug Discovery Market Concentration Rate

4.7.2 Global Top 3 and Top 6 Computer-Aided Drug Discovery Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans



5 Global Computer-Aided Drug Discovery Market Historical Development by Geographic Region (2021-2026)

5.1 Global Computer-Aided Drug Discovery Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global Computer-Aided Drug Discovery Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America Computer-Aided Drug Discovery Market Status by Country (2021-2026)

5.3.1 North America Computer-Aided Drug Discovery Sales Volume by Country (2021-2026)

5.3.2 North America Computer-Aided Drug Discovery Revenue by Country (2021-2026)

5.3.3 United States Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe Computer-Aided Drug Discovery Market Status by Country (2021-2026)

5.4.1 Europe Computer-Aided Drug Discovery Sales Volume by Country (2021-2026)

5.4.2 Europe Computer-Aided Drug Discovery Revenue by Country (2021-2026)

5.4.3 Germany Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific Computer-Aided Drug Discovery Market Status by Country (2021-2026)

5.5.1 Asia Pacific Computer-Aided Drug Discovery Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific Computer-Aided Drug Discovery Revenue by Country (2021-2026)

5.5.3 China Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America Computer-Aided Drug Discovery Market Status by Country (2021-2026)

5.6.1 Latin America Computer-Aided Drug Discovery Sales Volume by Country (2021-2026)

5.6.2 Latin America Computer-Aided Drug Discovery Revenue by Country (2021-2026)

5.6.3 Mexico Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa Computer-Aided Drug Discovery Market Status by Country (2021-2026)

5.7.1 Middle East and Africa Computer-Aided Drug Discovery Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa Computer-Aided Drug Discovery Revenue by Country (2021-2026)

5.7.3 GCC Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa Computer-Aided Drug Discovery Sales Volume, Revenue and Growth (2021-2026)



6 Global Computer-Aided Drug Discovery Market Historical Development by Product Type (2021-2026)

6.1 Computer-Aided Drug Discovery Definition by Type

6.2 Global Computer-Aided Drug Discovery Historical Sales Volume by Product Type (2021-2026)

6.3 Global Computer-Aided Drug Discovery Historical Revenue by Product Type (2021-2026)

6.4 Global Computer-Aided Drug Discovery Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global Computer-Aided Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Ligand-Based Drug Design (2021-2026)
6.5.2 Global Computer-Aided Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Sequence-Based Approaches (2021-2026)
6.5.3 Global Computer-Aided Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Structure-Based Drug Design (2021-2026)


7 Global Computer-Aided Drug Discovery Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global Computer-Aided Drug Discovery Historical Sales Volume by End User (2021-2026)

7.3 Global Computer-Aided Drug Discovery Historical Revenue by End User (2021-2026)

7.4 Global Computer-Aided Drug Discovery Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global Computer-Aided Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Biotechnology Companies (2021-2026)
7.5.2 Global Computer-Aided Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Pharmaceutical Companies (2021-2026)
7.5.3 Global Computer-Aided Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Research Laboratories (2021-2026)


8 Leading Companies Profiles

8.1 Eli Lilly and Company
8.1.1 Eli Lilly and Company Corporation Information
8.1.2 Eli Lilly and Company - Computer-Aided Drug Discovery Product Portfolio and Specification
8.1.3 Eli Lilly and Company Performance Analysis (2021-2026)
8.1.4 Eli Lilly and Company Business and Markets Served
8.1.5 Eli Lilly and Company Recent Developments
8.2 Novartis AG
8.2.1 Novartis AG Corporation Information
8.2.2 Novartis AG - Computer-Aided Drug Discovery Product Portfolio and Specification
8.2.3 Novartis AG Performance Analysis (2021-2026)
8.2.4 Novartis AG Business and Markets Served
8.2.5 Novartis AG Recent Developments
8.3 Gilead Sciences, Inc.
8.3.1 Gilead Sciences, Inc. Corporation Information
8.3.2 Gilead Sciences, Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.3.3 Gilead Sciences, Inc. Performance Analysis (2021-2026)
8.3.4 Gilead Sciences, Inc. Business and Markets Served
8.3.5 Gilead Sciences, Inc. Recent Developments
8.4 AstraZeneca PLC
8.4.1 AstraZeneca PLC Corporation Information
8.4.2 AstraZeneca PLC - Computer-Aided Drug Discovery Product Portfolio and Specification
8.4.3 AstraZeneca PLC Performance Analysis (2021-2026)
8.4.4 AstraZeneca PLC Business and Markets Served
8.4.5 AstraZeneca PLC Recent Developments
8.5 Simulations Plus, Inc.
8.5.1 Simulations Plus, Inc. Corporation Information
8.5.2 Simulations Plus, Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.5.3 Simulations Plus, Inc. Performance Analysis (2021-2026)
8.5.4 Simulations Plus, Inc. Business and Markets Served
8.5.5 Simulations Plus, Inc. Recent Developments
8.6 Regeneron Pharmaceuticals, Inc.
8.6.1 Regeneron Pharmaceuticals, Inc. Corporation Information
8.6.2 Regeneron Pharmaceuticals, Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.6.3 Regeneron Pharmaceuticals, Inc. Performance Analysis (2021-2026)
8.6.4 Regeneron Pharmaceuticals, Inc. Business and Markets Served
8.6.5 Regeneron Pharmaceuticals, Inc. Recent Developments
8.7 GlaxoSmithKline PLC
8.7.1 GlaxoSmithKline PLC Corporation Information
8.7.2 GlaxoSmithKline PLC - Computer-Aided Drug Discovery Product Portfolio and Specification
8.7.3 GlaxoSmithKline PLC Performance Analysis (2021-2026)
8.7.4 GlaxoSmithKline PLC Business and Markets Served
8.7.5 GlaxoSmithKline PLC Recent Developments
8.8 Vertex Pharmaceuticals Incorporated
8.8.1 Vertex Pharmaceuticals Incorporated Corporation Information
8.8.2 Vertex Pharmaceuticals Incorporated - Computer-Aided Drug Discovery Product Portfolio and Specification
8.8.3 Vertex Pharmaceuticals Incorporated Performance Analysis (2021-2026)
8.8.4 Vertex Pharmaceuticals Incorporated Business and Markets Served
8.8.5 Vertex Pharmaceuticals Incorporated Recent Developments
8.9 Boehringer Ingelheim International GmbH
8.9.1 Boehringer Ingelheim International GmbH Corporation Information
8.9.2 Boehringer Ingelheim International GmbH - Computer-Aided Drug Discovery Product Portfolio and Specification
8.9.3 Boehringer Ingelheim International GmbH Performance Analysis (2021-2026)
8.9.4 Boehringer Ingelheim International GmbH Business and Markets Served
8.9.5 Boehringer Ingelheim International GmbH Recent Developments
8.10 Sanofi S.A.
8.10.1 Sanofi S.A. Corporation Information
8.10.2 Sanofi S.A. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.10.3 Sanofi S.A. Performance Analysis (2021-2026)
8.10.4 Sanofi S.A. Business and Markets Served
8.10.5 Sanofi S.A. Recent Developments
8.11 Bayer AG
8.11.1 Bayer AG Corporation Information
8.11.2 Bayer AG - Computer-Aided Drug Discovery Product Portfolio and Specification
8.11.3 Bayer AG Performance Analysis (2021-2026)
8.11.4 Bayer AG Business and Markets Served
8.11.5 Bayer AG Recent Developments
8.12 Dassault Systèmes SE
8.12.1 Dassault Systèmes SE Corporation Information
8.12.2 Dassault Systèmes SE - Computer-Aided Drug Discovery Product Portfolio and Specification
8.12.3 Dassault Systèmes SE Performance Analysis (2021-2026)
8.12.4 Dassault Systèmes SE Business and Markets Served
8.12.5 Dassault Systèmes SE Recent Developments
8.13 AbbVie Inc.
8.13.1 AbbVie Inc. Corporation Information
8.13.2 AbbVie Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.13.3 AbbVie Inc. Performance Analysis (2021-2026)
8.13.4 AbbVie Inc. Business and Markets Served
8.13.5 AbbVie Inc. Recent Developments
8.14 Chemical Computing Group Inc.
8.14.1 Chemical Computing Group Inc. Corporation Information
8.14.2 Chemical Computing Group Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.14.3 Chemical Computing Group Inc. Performance Analysis (2021-2026)
8.14.4 Chemical Computing Group Inc. Business and Markets Served
8.14.5 Chemical Computing Group Inc. Recent Developments
8.15 Merck & Co., Inc.
8.15.1 Merck & Co., Inc. Corporation Information
8.15.2 Merck & Co., Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.15.3 Merck & Co., Inc. Performance Analysis (2021-2026)
8.15.4 Merck & Co., Inc. Business and Markets Served
8.15.5 Merck & Co., Inc. Recent Developments
8.16 Roche Holding AG
8.16.1 Roche Holding AG Corporation Information
8.16.2 Roche Holding AG - Computer-Aided Drug Discovery Product Portfolio and Specification
8.16.3 Roche Holding AG Performance Analysis (2021-2026)
8.16.4 Roche Holding AG Business and Markets Served
8.16.5 Roche Holding AG Recent Developments
8.17 Schrodinger, Inc.
8.17.1 Schrodinger, Inc. Corporation Information
8.17.2 Schrodinger, Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.17.3 Schrodinger, Inc. Performance Analysis (2021-2026)
8.17.4 Schrodinger, Inc. Business and Markets Served
8.17.5 Schrodinger, Inc. Recent Developments
8.18 Bio-Rad Laboratories, Inc.
8.18.1 Bio-Rad Laboratories, Inc. Corporation Information
8.18.2 Bio-Rad Laboratories, Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.18.3 Bio-Rad Laboratories, Inc. Performance Analysis (2021-2026)
8.18.4 Bio-Rad Laboratories, Inc. Business and Markets Served
8.18.5 Bio-Rad Laboratories, Inc. Recent Developments
8.19 Pfizer Inc.
8.19.1 Pfizer Inc. Corporation Information
8.19.2 Pfizer Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.19.3 Pfizer Inc. Performance Analysis (2021-2026)
8.19.4 Pfizer Inc. Business and Markets Served
8.19.5 Pfizer Inc. Recent Developments
8.20 Accelrys, Inc.
8.20.1 Accelrys, Inc. Corporation Information
8.20.2 Accelrys, Inc. - Computer-Aided Drug Discovery Product Portfolio and Specification
8.20.3 Accelrys, Inc. Performance Analysis (2021-2026)
8.20.4 Accelrys, Inc. Business and Markets Served
8.20.5 Accelrys, Inc. Recent Developments


9 Global Computer-Aided Drug Discovery Market Forecast by Product Type and End User (2026-2034)

9.1 Global Computer-Aided Drug Discovery Market Forecast by Product Type (2026-2034)

9.1.1 Global Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Ligand-Based Drug Design (2026-2034)
9.1.2 Global Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Sequence-Based Approaches (2026-2034)
9.1.3 Global Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Structure-Based Drug Design (2026-2034)
9.2 Global Computer-Aided Drug Discovery Market Forecast by End User (2026-2034)

9.2.1 Global Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Biotechnology Companies (2026-2034)
9.2.2 Global Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Pharmaceutical Companies (2026-2034)
9.2.3 Global Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Research Laboratories (2026-2034)


10 Global Computer-Aided Drug Discovery Market Forecast by Geographic Region (2026-2034)

10.1 Global Computer-Aided Drug Discovery Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa Computer-Aided Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)



11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer